Conduct / Assessment of BE [Design Issues]

posted by joyjac – Philippines, 2006-05-23 05:50 (7323 d 22:02 ago) – Posting: # 134
Views: 11,291

Dear HS,

How would you conduct/assess BE of 2 drug products of the same active ingredient but of different dosage formats and strengths i.e. immediate-release, 130 mg per tablet versus sustained-release, 200 mg per tablet? Thanks.

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
143 visitors (0 registered, 143 guests [including 41 identified bots]).
Forum time: 03:52 CEST (Europe/Vienna)

There are no dangerous thoughts;
thinking itself is dangerous.    Hannah Arendt

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5